These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 7770119

  • 1. Accumulation of hippocampal cholinergic neurostimulating peptide (HCNP)-related components in Hirano bodies.
    Mitake S, Ojika K, Katada E, Otsuka Y, Matsukawa N, Fujimori O.
    Neuropathol Appl Neurobiol; 1995 Feb; 21(1):35-40. PubMed ID: 7770119
    [Abstract] [Full Text] [Related]

  • 2. Possible implication of hippocampal cholinergic neurostimulating peptide (HCNP)-related components in Hirano body formation.
    Mitake S, Katada E, Otsuka Y, Matsukawa N, Iwase T, Tsugu T, Fujimori O, Ojika K.
    Neuropathol Appl Neurobiol; 1996 Oct; 22(5):440-5. PubMed ID: 8930956
    [Abstract] [Full Text] [Related]

  • 3. Hirano bodies and Alzheimer's disease.
    Mitake S, Ojika K, Hirano A.
    Kaohsiung J Med Sci; 1997 Jan; 13(1):10-8. PubMed ID: 9130818
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hippocampal cholinergic neurostimulating peptides (HCNP).
    Ojika K, Mitake S, Tohdoh N, Appel SH, Otsuka Y, Katada E, Matsukawa N.
    Prog Neurobiol; 2000 Jan; 60(1):37-83. PubMed ID: 10622376
    [Abstract] [Full Text] [Related]

  • 6. Reduced Cholinergic Activity in the Hippocampus of Hippocampal Cholinergic Neurostimulating Peptide Precursor Protein Knockout Mice.
    Madokoro Y, Yoshino Y, Kato D, Sato T, Mizuno M, Kanamori T, Shimazawa M, Hida H, Hara H, Yoshida M, Borlongan CV, Ojika K, Matsukawa N.
    Int J Mol Sci; 2019 Oct 28; 20(21):. PubMed ID: 31661900
    [Abstract] [Full Text] [Related]

  • 7. Direct Enhancement Effect of Hippocampal Cholinergic Neurostimulating Peptide on Cholinergic Activity in the Hippocampus.
    Madokoro Y, Kato D, Tsuda Y, Arakawa I, Suzuki K, Sato T, Mizuno M, Uchida Y, Ojika K, Matsukawa N.
    Int J Mol Sci; 2023 May 17; 24(10):. PubMed ID: 37240261
    [Abstract] [Full Text] [Related]

  • 8. Demonstration of deacetylated hippocampal cholinergic neurostimulating peptide and its precursor protein in rat tissues.
    Ojika K, Katada E, Tohdoh N, Mitake S, Otsuka Y, Matsukawa N, Tsugu Y.
    Brain Res; 1995 Dec 01; 701(1-2):19-27. PubMed ID: 8925283
    [Abstract] [Full Text] [Related]

  • 9. NMDA receptor activation enhances the release of a cholinergic differentiation peptide (HCNP) from hippocampal neurons in vitro.
    Ojika K, Tsugu Y, Mitake S, Otsuka Y, Katada E.
    Brain Res Dev Brain Res; 1998 Mar 12; 106(1-2):173-80. PubMed ID: 9555001
    [Abstract] [Full Text] [Related]

  • 10. Distribution of hippocampal cholinergic neurostimulating peptide (HCNP) immunoreactivity in the central nervous system of the rat.
    Mitake S, Ojika K, Katada E, Otsuka Y, Matsukawa N, Fujimori O.
    Brain Res; 1996 Jan 08; 706(1):57-70. PubMed ID: 8720492
    [Abstract] [Full Text] [Related]

  • 11. [The involvement of hippocampal cholinergic neurostimulating peptide and its precursor in Alzheimer pathogenesis].
    Matsukawa N.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2014 Jun 08; 34(3):93-100. PubMed ID: 25076779
    [Abstract] [Full Text] [Related]

  • 12. Reduction of glutamatergic activity through cholinergic dysfunction in the hippocampus of hippocampal cholinergic neurostimulating peptide precursor protein knockout mice.
    Suzuki K, Ohi Y, Sato T, Tsuda Y, Madokoro Y, Mizuno M, Adachi K, Uchida Y, Haji A, Ojika K, Matsukawa N.
    Sci Rep; 2022 Nov 10; 12(1):19161. PubMed ID: 36357544
    [Abstract] [Full Text] [Related]

  • 13. Differential expression of HCNP-related antigens in hippocampus in senescence-accelerated mice.
    Yamada K, Matsukawa N, Yuasa H, Hattori M, Nakazawa H, Borlongan CV, Ojika K.
    Brain Res; 2007 Jul 16; 1158():169-75. PubMed ID: 17570350
    [Abstract] [Full Text] [Related]

  • 14. Co-localization of hippocampal cholinergic neurostimulating peptide precursor with collapsin response mediator protein-2 at presynaptic terminals in hippocampus.
    Kato D, Mitake S, Mizuno M, Kanamori T, Suzuki T, Ojika K, Matsukawa N.
    Neurosci Lett; 2012 May 31; 517(2):92-7. PubMed ID: 22542739
    [Abstract] [Full Text] [Related]

  • 15. Brain malformations caused by retroviral vector-mediated gene transfer of hippocampal cholinergic neurostimulating peptide precursor protein into the CNS via embryonic mice ventricles.
    Matsukawa N, Ikenaka K, Nanmoku K, Yuasa H, Hattori M, Kawano M, Nakazawa H, Fujimori O, Ueda R, Ojika K.
    Dev Neurosci; 2003 May 31; 25(5):349-56. PubMed ID: 14614262
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.